Case Reports in Medicine / 2014 / Article / Tab 1

Case Report

A Case Series of Emphysematous Pyelonephritis

Table 1

Patient laboratory data and antibiotic treatment.

Case/dataMetabolic panelBlood countUrine analysisAntibiotics

Case  1Na+ 125 mEq/L
K+ 6.6 mEq/L
Cl 87 mEq/L
HC 24 mEq/L
BUN 23 mg/dL
Cr 2.7 mg/dL
Glu 917 mg/dL
WBC 12.5 k/mm3  
Hgb 14 g/dL
Hct 41%
Plt 273 k/mm3
Turbid
4+ bacteria
>100 WBC
>100 RBC
3+ blood
2+ leukocyte esterase
Nitrate negative
Empiric Nafcillin 1 g IV q6 followed by Vancomycin 1 g IV q12 for 14-day monotherapy based on susceptibility results

Case  2Na+ 140 mEq/L
K+ 4.2 mEq/L
Cl 104 mEq/L
HC 22 mEq/L
BUN 32 mg/dL
Cr 2.9 mg/dL
Glu 98 mg/dL
WBC 16.8 k/mm3  
Hgb 11.5 g/dL
Hct 37.6%
Plt 271 k/mm3
Turbid
1+ bacteria
20–50 WBC
0 RBC
1+ leukocyte esterase
Nitrate positive
Empiric Cefepime 1 g IV q12 followed by Ceftriaxone 1 g IV q24 based on susceptibility results. Thereafter Ciprofloxacin 500 mg po q24 for 10 days based on susceptibility results

Case  3Na+ 143 mEq/L
K+ 3.6 mEq/L
Cl 109 mEq/L
HC 21 mEq/L
BUN 21 mg/dL
Cr 0.7 mg/dL
Glu 98 mg/dL
WBC 17.5 k/mm3  
Hgb 13.2 g/dL
Hct 41.9%
Plt 224 k/mm3
Turbid
4+ bacteria
>100 WBC
>100 RBC
3+ blood
3+ leukocyte esterase
Nitrate negative
Empiric Ciprofloxacin 400 mg IV q12 followed by Bactrim DS po BID for 30 days based on susceptibility results

Case  4Na+ 136 mEq/L
K+ 4.7 mEq/L
Cl 104 mEq/L
HC 24 mEq/L
BUN 12 mg/dL
Cr 1.2 mg/dL
Glu 105 mg/dL
WBC 18.8 k/mm3  
Hgb 10.4 g/dL
Hct 29.7%
Plt 387 k/mm3
Turbid
24+ bacteria
10–20 WBC
5–10 RBC
1+ blood
3+ leukocyte esterase
Nitrate positive
Empiric Zosyn 3.3.7 IV q6 and IV Ceftriaxone 2 gm q24 followed by Ciprofloxacin 400 mg IV q12 along with Ceftriaxone 2 gm IV q24 g for a total of 14 days based on susceptibility results

Case  5Na+ 138 mEq/L
K+ 4.6 mEq/L
Cl 109 mEq/L
HC 19 mEq/L
BUN 65 mg/dL
Cr 6.5 mg/dL
Glu 72 mg/dL
WBC 17.3 k/mm3  
Hgb 9.7 g/dL
Hct 30.3%
Plt 293 k/mm3
Not available as patient is a hemodialysis patientUnasyn 3 g IV q24 and Imipenem 500 mg IV q6 for 14 days